|
|
|
Volumn 26, Issue 5 SUPPL., 1999, Pages 28-34
|
|
Novel approaches in myeloma therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BETA 2 MICROGLOBULIN;
BISPHOSPHONIC ACID DERIVATIVE;
C REACTIVE PROTEIN;
CARMUSTINE;
CD34 ANTIGEN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
MELPHALAN;
PREDNISONE;
THALIDOMIDE;
VINCRISTINE;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CYTOGENETICS;
DENDRITIC CELL;
DRUG MEGADOSE;
DRUG TARGETING;
EDITORIAL;
GRAFT VERSUS LEUKEMIA EFFECT;
HUMAN;
MAINTENANCE THERAPY;
MULTIPLE MYELOMA;
MYELODYSPLASIA;
NONHUMAN;
PERIPHERAL BLOOD STEM CELL;
PRIORITY JOURNAL;
REMISSION;
STEM CELL TRANSPLANTATION;
VACCINATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROMES;
PROGNOSIS;
|
|
EID: 0032848116
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (21)
|
|
References (26)
|
